Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea
home - Laotian Times [Unofficial]
March 19, 2026
Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ — Crescel LLC, an innovative science and technology company, today announced results from a double-blind, randomized, active comparator-controlled clinical trial evaluating its biobotanical Skin Renewal Cream compared to a commonly used standard of care—topical metronidazole (Metrocream®) combined with CeraVe® moisturizer—in individuals […]
Discussion in the ATmosphere